Elsevier

Pathology

Volume 44, Issue 5, August 2012, Pages 448-452
Pathology

Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer

https://doi.org/10.1097/PAT.0b013e32835576eeGet rights and content

Summary

Aims

CD151 belongs to the group of tetraspanins and is aberrantly expressed in different tumours and differential expression has been associated with prognosis. The aim of this study was to clarify the relationship of CD151 expression with tumour phenotype and clinical outcome in bladder cancer.

Methods

A bladder cancer tissue microarray containing samples from 686 urothelial bladder cancers was analysed by immunohistochemistry.

Results

Membranous CD151 immunostaining was recorded in 409 (66.0%) of 620 analysable cases. High CD151 expression was seen in normal urothelium and in most non-invasive tumours. Low CD151 expression levels were associated with a more unfavourable tumour phenotype. CD151 staining was seen in 71.5% of 284 pTa, 62.1% of 145 pT1 and 60.4% of 187 pT2-4 cancers (p = 0.0033). CD151 staining was detectable in 77.3% of 75 grade 1, 71.1% of 273 grade 2 and 57.7% of 272 grade 3 cancers (p < 0.0001). CD151 expression status was not associated with overall or tumour-specific survival in muscle-invasive cancers (pT2-4), tumour progression in pT1 and recurrences in pTa tumours.

Conclusion

On the basis of our data we conclude that loss of CD151 may contribute to bladder cancer progression through attenuation of cell adhesion. In clinically defined subgroups CD151 expression does not provide additional prognostic information.

References (31)

  • L.M. Sterk et al.

    The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin alpha6-beta4 and may regulate the spatial organization of hemidesmosomes

    J Cell Biol

    (2000)
  • M. Yanez-Mo et al.

    Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/ PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions

    J Cell Biol

    (1998)
  • J. Ang et al.

    CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a new prognostic indicator?

    Cancer Epidemiol Biomarkers Prev

    (2004)
  • T. Tokuhara et al.

    Clinical significance of CD151 gene expression in nonsmall cell lung cancer

    Clin Cancer Res

    (2001)
  • A.W. Ke et al.

    Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma

    Hepatology

    (2009)
  • Cited by (11)

    View all citing articles on Scopus
    #

    these authors contributed equally to this work

    View full text